By Assoc. Prof. Dr. Mehmet Sorar | Published: 09.02.2025
Parkinson’s Disease Surgery in Ankara: Treatment Centers and Specialist Physicians
Surgery for Parkinson’s disease is an option for selected people whose symptoms are not controlled well enough by medicines. The main operation is deep brain stimulation (DBS). Lesioning procedures, such as pallidotomy and focused ultrasound, are the other family. This page explains the options, who gets referred and how to judge a surgical team. It does not name or rank any centre or physician in Ankara.
Which operations are used for Parkinson’s disease?
There are two families of surgery. DBS places electrodes in a movement-control area of the brain and delivers electrical pulses from a generator in the chest, while lesioning procedures deliberately destroy a small area of tissue. The table shows how the International Parkinson and Movement Disorder Society (MDS) rates each one, or what US regulators approved.
| Operation | What it involves | Rating or approval |
|---|---|---|
| Bilateral subthalamic nucleus (STN) DBS | Electrodes on both sides, generator under the collarbone | MDS 2018: clinically useful for motor fluctuations (times when medicine wears off and symptoms return) and dyskinesia (involuntary jerky movements). MDS 2025: efficacious for motor fluctuations. |
| Bilateral globus pallidus internus (GPi) DBS | Same system, different target | MDS 2018: clinically useful for the same problems. MDS 2025: likely efficacious. |
| Pallidotomy | Thermal destruction of part of the globus pallidus | MDS 2025: likely efficacious. |
| MR-guided focused ultrasound pallidotomy | Treats one side of the brain under MRI guidance | Approved by the US Food and Drug Administration (FDA) on 29 October 2021 for people aged 30 or older with advanced Parkinson’s and medicine-resistant moderate to severe motor complications, as an addition to medicine. |
The published summaries of the MDS reviews do not rate focused ultrasound, and the trial behind the FDA approval compared it with a sham (pretend) procedure, not with DBS. That approval applies to the United States, so ask your doctor whether the treatment is available in Türkiye.
When is surgery considered?
Surgery is usually discussed once medicines stop controlling symptoms well. The Parkinson’s Foundation lists these features of a typical DBS candidate:
- A diagnosis confirmed by a specialist and some benefit from levodopa, the most widely used Parkinson’s medicine.
- Continued “off” time (periods when medicine is not controlling symptoms) or medicine side effects despite adjustments, or tremor that does not respond to medicine.
- No serious mood, mental-health or cognitive problems.
- Good enough health for surgery and support during recovery.
The Foundation gives no age limit. It adds that the 2016 FDA approval covered earlier-stage disease, with at least four years since diagnosis and movement symptoms not adequately controlled by medicine. The NHS, the UK’s public health service, says DBS is available only at specialist neuroscience centres and is not suitable for everyone. A 2025 MDS evidence review of 102 randomised trials, in people already taking oral levodopa, places surgery beside advanced drug therapies as one option for motor fluctuations. The NHS also lists non-oral drug options for fluctuations that are hard to control, so surgery is not the only next step. Keep taking your medicines as prescribed while these options are discussed, and do not stop or change them on your own.
Who refers you to a neurosurgeon, and what happens at the first visit?
Cleveland Clinic says referral usually comes from a primary care provider or a neurologist, and that a referral does not necessarily mean you need surgery, because neurosurgeons typically try non-surgical treatment first. The visit includes a comprehensive neurological examination, a review of symptoms and history, and detailed imaging, and the plan may be non-surgical, surgical or both.
The Parkinson’s Foundation adds that work-up before DBS includes a symptom and cognitive evaluation and an MRI or CT scan to guide surgery. Cleveland Clinic suggests bringing copies of outside test results, images and lab work, a list of every medicine, supplement, vitamin and herbal product, a list of allergies, your main questions and any new or changed symptoms, and a friend or relative to take notes.
How can you judge a surgical team in Ankara?
The questions below apply to any centre, in Ankara or elsewhere:
- Does the assessment cover examination, history, imaging and a cognitive evaluation?
- Are non-surgical options discussed as well? Cleveland Clinic says they are usually tried first.
- Are risks explained clearly? The Parkinson’s Foundation lists temporary pain, numbness, swelling, infection, allergic reaction to implant materials, temporary confusion (especially in older adults) and rare seizures, but gives no percentages.
- Which target is proposed and why? The Foundation says the choice depends on symptoms and goals.
- Who will programme the stimulator after surgery, and how often are visits? The Foundation says initial programming takes several visits, some centres schedule visits every 1 to 2 months in the first six months, and remote programming is not offered at every clinic.
- Which specialists are on the team, how long is the expected hospital stay, and is a second opinion welcome? Cleveland Clinic lists all three among questions for a surgeon.
Cleveland Clinic also lists the surgeon’s experience with this type of operation, without setting a minimum number of cases.
What can surgery not do?
The 2018 MDS review found no intervention that prevents or delays Parkinson’s progression, so the rated benefit is for motor fluctuations and dyskinesia, not for the course of the disease. The Parkinson’s Foundation says DBS may not help mood, energy or walking if these did not respond to levodopa before surgery. The NHS states that DBS does not cure Parkinson’s but can ease symptoms for some people.
Harms are reported for focused ultrasound too. In the FDA summary, adverse events occurred in 43 of 68 treated people (63.2%) and 12 of 24 sham-treated people (50%), and 91% of events in the treated group were mild or moderate. Serious events occurred in 10 treated people (14.7%), against one event in the sham group. At three months, 68.6% of treated people were responders (people who improved by a set amount) against 33.3% with sham, but only 91 of 166 enrolled people (54.8%) were available for the main analysis, which limits certainty. Evidence on DBS itself is set out in deep brain stimulation in Parkinson’s disease.
When should you ask for a surgical assessment?
Persistent off time, medicine side effects despite adjustments or tremor that does not respond to medicine are reasons to raise surgery with the neurologist who manages your medicines. There is no set deadline for a surgical assessment, and the decision follows an examination.
If you have already had DBS, treat sudden weakness, a seizure, trouble speaking or sudden confusion as an emergency and call emergency services (112 in Türkiye). Fever, or redness or discharge at a wound, needs a call to the surgical team the same day. Life after Parkinson’s surgery lists the warning signs in full. For the stages of care after the decision, see the treatment and rehabilitation process, and for the condition itself, what Parkinson’s disease is.
Sources
- MDS evidence-based medicine review: treatments for the motor symptoms of Parkinson’s disease (2018)
- MDS evidence-based medicine review: treatments for Parkinson’s disease motor fluctuations (2025)
- FDA: Summary of safety and effectiveness data, focused ultrasound for Parkinson’s pallidotomy (2021)
- Parkinson’s Foundation: Deep brain stimulation
- NHS: Parkinson’s disease, treatment (reviewed 2022)
- Cleveland Clinic: Neurosurgeon, what they do (2022)
This article is for general information and does not replace medical diagnosis or treatment. Please consult your physician for advice about your own condition.
Assoc. Prof. Dr. Mehmet Sorar
Neurosurgeon in Ankara. Graduated from Gazi University Faculty of Medicine in 1997, specialist since 2004, associate professor since 2019. Full CV
Related treatment page: Parkinson